Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 4;6(3):e14748.
doi: 10.1371/journal.pone.0014748.

Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence

Janet M McNicholl  1 , J Steven McDougal, Punneeporn Wasinrapee, Bernard M Branson, Michael Martin, Jordan W Tappero, Philip A Mock, Timothy A Green, Dale J Hu, Bharat Parekh; Thai-U.S. BED Assay Validation Working Group
Collaborators, Affiliations

Assessment of BED HIV-1 incidence assay in seroconverter cohorts: effect of individuals with long-term infection and importance of stable incidence

Janet M McNicholl et al. PLoS One. .

Abstract

Background: Performance of the BED assay in estimating HIV-1 incidence has previously been evaluated by using longitudinal specimens from persons with incident HIV infections, but questions remain about its accuracy. We sought to assess its performance in three longitudinal cohorts from Thailand where HIV-1 CRF01_AE and subtype B' dominate the epidemic.

Design: BED testing was conducted in two longitudinal cohorts with only incident infections (a military conscript cohort and an injection drug user cohort) and in one longitudinal cohort (an HIV-1 vaccine efficacy trial cohort) that also included long-term infections.

Methods: Incidence estimates were generated conventionally (based on the number of annual serocoversions) and by using BED test results in the three cohorts. Adjusted incidence was calculated where appropriate.

Results: For each longitudinal cohort the BED incidence estimates and the conventional incidence estimates were similar when only newly infected persons were tested, whether infected with CRF01_AE or subtype B'. When the analysis included persons with long-term infections (to mimic a true cross-sectional cohort), BED incidence estimates were higher, although not significantly, than the conventional incidence estimates. After adjustment, the BED incidence estimates were closer to the conventional incidence estimates. When the conventional incidence varied over time, as in the early phase of the injection drug user cohort, the difference between the two estimates increased, but not significantly.

Conclusions: Evaluation of the performance of incidence assays requires the inclusion of a substantial number of cohort-derived specimens from individuals with long-term HIV infection and, ideally, the use of cohorts in which incidence remained stable. Appropriate adjustments of the BED incidence estimates generate estimates similar to those generated conventionally.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: CDC receives royalties in relation to the BED assay. These are distributed, in part, to the Laboratory Branches where JSM and BSP work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

References

    1. Rutherford GW, Schwarcz SK, McFarland W. Surveillance for incident HIV Infection: new technology and new opportunities. J Acquir Immune Defic Syndr. 2000;25:S115–S119. - PubMed
    1. Rehle T, Lazzari S, Dallabetta G, Asamoah-Odei E. Second-generation HIV surveillance: better data for decision-making. Bull World Heath Organ. 2004;82:121–127. - PMC - PubMed
    1. McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, et al. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS. 2005;19:S25–S30. - PubMed
    1. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, et al. Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS. 2010;24:2763–71. - PubMed
    1. Brookmeyer R, Gail MH. AIDS Epidemiology: A Quantitative Approach. New York: Oxford University Press; 1994.

Publication types